spacer
home > ict > autumn 2019 > a decentralised ecosystem
PUBLICATIONS
International Clinical Trials

A Decentralised Ecosystem





Digital disruption in clinical research has been a constant for over 20 years; however, ensuring that this is still relevant where ‘the rubber hits the road’ has been a challenge (or roadblock, sticking with the metaphor). Following my recent attendance at the annual conference of the Society of Clinical Data Managers, I believe the momentum is now greater, and there is an appetite for change. This change is to how and where we capture and analyse the valuable data that are provided by human subjects who volunteer to take part in clinical trials.

Of many presentations and panel discussions, there was so much enthusiasm from inquisitive minds in our industry. While the day-to-day work of clinical research is pressurised, the professionals and experts in our industry are determined to advance processes that can improve data quality, reduce the risks on clinical trials, and improve safety and outcomes for patients, while also working to increase efficiency through cost and cycle time reductions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Ian O’Shaughnessy has over 22 years of experience in clinical research working at CROs. The first part of his career was spent in roles of increasing responsibility in clinical data management and programming. This included leading regional data management organisations for ICON in Europe and Asia Pacific. Since 2013, Ian has worked in the field of risk-based monitoring, developing ICON’s methodology, processes, and systems. He has worked directly with sponsor companies on early engagement and implementing risk-based clinical strategies. Ian holds a Bachelor’s in Genetics from Trinity College Dublin, Ireland, and postgraduate qualifications in Business, Management, and Information Technology.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Biognosys Announces the Launch of its Next-Generation Plasma Biomarker Discovery Solution

October 5th, 2021 – SCHLIEREN, (Zurich, Switzerland). Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, today announces the upcoming launch of its next-generation plasma biomarker discovery solution.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement